Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse

Human Molecular Genetics

Volumn 18, Issue 7, 2009, Pages 1252-1265

  Way, Sharon W ^a   Mckenna III, James ^a   Mietzsch, Ulrike ^a   Reith, R Michelle ^a   Wu, Henry Cheng Ju ^a   Gambello, Michael J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN S6; TUBERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; CELL ENLARGEMENT; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE LOSS; GLIA CELL; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; MOUSE; MYELINATION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEM CELL; TUBEROUS SCLEROSIS; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; INTEGRASES; MICE; MYELIN SHEATH; NEUROGLIA; NEURONAL MIGRATION DISORDERS; NEURONS; OLIGODENDROGLIA; STEM CELLS; TRANSCRIPTION FACTORS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 63149114250     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp025     Document Type: Article

References (76)

1. Crino, P.B., Nathanson, K.L. and Henske, E.P. (2006) The tuberous sclerosis complex. N. Engl. J. Med., 355, 1345-1356.
2. Consortium. (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 75, 1305-1315.
3. van Slegtenhorst, M., de Hoogt, R., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., van den Ouweland, A., Halley, D., Young, J. et al. (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science, 277, 805-808.
4. Cheadle, J.P., Reeve, M.P., Sampson, J.R. and Kwiatkowski, D.J. (2000) Molecular genetic advances in tuberous sclerosis. Hum. Genet., 107, 97-114.
5. Chan, J.A., Zhang, H., Roberts, P.S., Jozwiak, S., Wieslawa, G., Lewin-Kowalik, J., Kotulska, K. and Kwiatkowski, D.J. (2004) Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J. Neuropathol. Exp. Neurol, 63, 1236-1242.
6. Gomez, M.R. (1999) Tuberous Sclerosis Complex, 3rd edn. Oxford University Press, New York.
7. DiMario, F.J. Jr. (2004) Brain abnormalities in tuberous sclerosis complex. J. Child Neurol., 19, 650-657.
8. Thiele, E.A. (2004) Managing epilepsy in tuberous sclerosis complex. J. Child Neurol., 19, 680-686.
9. Prather, P. and de Vries, P.J. (2004) Behavioral and cognitive aspects of tuberous sclerosis complex. J. Child Neurol., 19, 666-674.
10. Smalley, S.L. (1998) Autism and tuberous sclerosis. J. Autism Dev. Disord., 28, 407-414.
11. Tapon, N., Ito, N., Dickson, B.J., Treisman, J.E. and Hariharan, I.K. (2001) The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell, 105, 345-355.
12. Sarbassov, D.D., Ali, S.M. and Sabatini, D.M. (2005) Growing roles for the mTOR pathway. Curr. Opin. Cell Biol., 17, 596-603.
13. Gao, X., Zhang, Y., Arrazola, P., Hino, O., Kobayashi, T., Yeung, R.S., Ru, B. and Pan, D. (2002) Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol., 4, 699-704.
14. Garami, A., Zwartkruis, F.J., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S.C., Hafen, E., Bos, J.L. and Thomas, G. (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell, 11, 1457-1466.
15. Zhang, Y., Gao, X., Saucedo, L.J., Ru, B., Edgar, B.A. and Pan, D. (2003) Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol., 5, 578-581.
16. Kim, D.H., Sarbassov, D.D., Ali, S.M., Latek, R.R., Guntur, K.V., Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2003) GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell, 11, 895-904.
17. Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell, 110, 163-175.
18. Crino, P.B. (2004) Molecular pathogenesis of tuber formation in tuberous sclerosis complex. J. Child Neurol., 19, 716-725.
19. Paghdal, K.V. and Schwartz, R.A. (2007) Sirolimus (rapamycin): From the soil of Easter Island to a bright future. J. Am. Acad. Dermatol., 57, 1046-1050.
20. Kenerson, H., Dundon, T.A. and Yeung, R.S. (2005) Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr. Res. 57, 67-75.
21. Lee, L., Sudentas, P., Donohue, B., Asrican, K., Worku, A., Walker, V., Sun, Y., Schmidt, K., Albert, M.S., El-Hashemite, N. et al. (2005) Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer, 42, 213-227.
22. Kwiatkowski, D.J., Zhang, H., Bandura, J.L., Heiberger, K.M., Glogauer, M., el-Hashemite, N. and Onda, H. (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet., 11 525-534.
23. Manning, B.D., Tee, A.R., Logsdon, M.N., Blenis, J. and Cantley, L.C. (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell, 10, 151-162.
24. Zeng, L.H., Xu, L., Gutmann, D.H. and Wong, M. (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann. Neurol. 63, 444-453.
25. Meikle, L., Pollizzi, K., Egnor, A., Kramvis, I., Lane, H., Sahin, M. and Kwiatkowski, D.J. (2008) Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt signaling lead to improved survival and function. J. Neurosci., 28, 5422-5432.
26. Bissler, J.J., McCormack, F.X., Young, L.R., Elwing, J.M., Chuck, G., Leonard, J.M., Schmithorst, V.J., Laor, T., Brody, A.S., Bean, J. et al. (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med., 358, 140-151.
27. Franz, D.N., Leonard, J., Tudor, C., Chuck, G., Care, M., Sethuraman, G., Dinopoulos, A., Thomas, G. and Crone, K.R. (2006) Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann. Neurol., 59, 490-498.
28. Park, S.H., Pepkowitz, S.H., Kerfoot, C., De Rosa, M.J., Poukens, V., Wienecke, R., DeClue, J.E. and Vinters, H.V. (1997) Tuberous sclerosis in a 20-week gestation fetus: Immunohistochemical study. Acta Neuropathol., 94, 180-186.
29. Crino, P.B., Trojanowski, J.Q., Dichter, M.A. and Eberwine, J. (1996) Embryonic neuronal markers in tuberous sclerosis: Single-cell molecular pathology. Proc. Natl Acad. Sci. USA, 93, 14152-14157.
30. Hirose, T., Scheithauer, B.W., Lopes, M.B., Gerber, H.A., Altermatt, H.J., Hukee, M.J., VandenBerg, S.R. and Charlesworth, J.C. (1995) Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: An immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathol., 90, 387-399.
31. Scheidenhelm, D.K. and Gutmann, D.H. (2004) Mouse models of tuberous sclerosis complex. J. Child Neurol., 19, 726-733.
32. Kobayashi, T., Minowa, O., Kuno, J., Mitani, H., Hino, O. and Noda, T. (1999) Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res. 59, 1206-1211.
33. Kobayashi, T., Minowa, O., Sugitani, Y., Takai, S., Mitani, H., Kobayashi, E., Noda, T. and Hino, O. (2001) A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc. Natl Acad. Sci. USA, 98, 8762-8767.
34. Onda, H., Lueck, A., Marks, P.W., Warren, H.B. and Kwiatkowski, D.J. (1999) Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J. Clin. Invest. 104, 687-695.
35. Wilson, C., Idziaszczyk, S., Parry, L., Guy, C., Griffiths, D.F., Lazda, E., Bayne, R.A., Smith, A.J., Sampson, J.R. and Cheadle, J.P. (2005) A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. Hum. Mol. Genet., 14, 1839-1850.
36. Uhlmann, E.J., Wong, M., Baldwin, R.L., Bajenaru, M.L., Onda, H., Kwiatkowski, D.J., Yamada, K. and Gutmann, D.H. (2002) Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann. Neurol., 52, 285-296.
37. Meikle, L., Talos, D.M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F.E. and Kwiatkowski, D.J. (2007) A mouse model of tuberous sclerosis: Neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J. Neurosci., 27, 5546-5558.
38. Wang, Y., Greenwood, J.S., Calcagnotto, M.E., Kirsch, H.E., Barbaro, N.M. and Baraban, S.C. (2007) Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann. Neurol., 61, 139-152.
39. Dabora, S.L., Jozwiak, S., Franz, D.N., Roberts, P.S., Nieto, A., Chung, J., Choy, Y.S., Reeve, M.P., Thiele, E., Egelhoff, J.C. et al. (2001) Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet., 68, 64-80.
40. Au, K.S., Williams, A.T., Roach, E.S., Batchelor, L., Sparagana, S.P., Delgado, M.R., Wheless, J.W., Baumgartner, J.E., Roa, B.B., Wilson, C.M. et al. (2007) Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet. Med., 9, 88-100.
41. Hernandez, O., Way, S., McKenna, J. III and Gambello, M.J. (2007) Generation of a conditional disruption of the Tsc2 gene. Genesis, 45, 101-106.
42. Campbell, K. and Gotz, M. (2002) Radial glia: Multi-purpose cells for vertebrate brain development. Trends Neurosci., 25, 235-238.
43. Noctor, S.C., Flint, A.C., Weissman, T.A., Dammerman, R.S. and Kriegstein, A.R. (2001) Neurons derived from radial glial cells establish radial units in neocortex. Nature, 409, 714-720.
44. Noctor, S.C., Flint, A.C., Weissman, T.A., Wong, W.S., Clinton, B.K. and Kriegstein, A.R. (2002) Dividing precursor cells of the embryonic cortical ventricular zone have morphological and molecular characteristics of radial glia. J. Neurosci., 22, 3161-3173.
45. Gotz, M. and Pinto, L. (2007) Radial glial cell heterogeneity - the source of diverse progeny in the CNS. Prog. Neurobiol., 83, 2-23.
46. Noctor, S., Martinez-Cerdeno, V., Ivic, L. and Kriegstein, A. (2004) Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nat. Neurosci., 7, 136-144.
47. Haubensak, W., Attardo, A., Denk, W. and Huttner, W. (2004) Neurons arise in the basal neuroepithelium of the early mammalian telencephalon: a major site of neurogenesis. Proc. Natl Acad. Sci. USA, 101 3196-3201.
48. Zhuo, L., Theis, M., Alvarez-Maya, I., Brenner, M., Willecke, K. and Messing, A. (2001) hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis, 31, 85-94.
49. Malatesta, P., Hack, M.A., Hartfuss, E., Kettenmann, H., Klinkert, W., Kirchhoff, F. and Gotz, M. (2003) Neuronal or glial progeny: Regional differences in radial glia fate. Neuron, 37, 751-764.
50. Ohkubo, Y., Uchida, A.O., Shin, D., Partanen, J. and Vaccarino, F.M. (2004) Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse. J. Neurosci., 24, 6057-6069.
51. Jozwiak, J. and Jozwiak, S. (2007) Giant cells: Contradiction to two-hit model of tuber formation? Cell Mol. Neurobiol., 27, 251-261.
52. Mizuguchi, M., Mori, M., Nozaki, Y., Momoi, M.Y., Itoh, M., Takashima, S. and Hino, O. (2004) Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis. Acta Neuropathol., 107, 47-52.
53. Benvenuto, G., Li, S., Brown, S.J., Braverman, R., Vass, W.C., Cheadle, J.P., Halley, D.J., Sampson, J.R., Wienecke, R. and DeClue, J.E. (2000) The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene, 19, 6306-6316.
54. Englund, C., Fink, A., Lau, C., Pham, D., Daza, R.A., Bulfone, A., Kowalczyk, T. and Hevner, R.F. (2005) Pax6, Tbr2 and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J. Neurosci., 25 247-251.
55. Sosunov, A.A., Wu, X., Weiner, H.L., Mikell, C.B., Goodman, R.R., Crino, P.D. and McKhann, G.M. II (2008). Tuberous sclerosis: A primary pathology of astrocytes? Epilepsia, 49 (Suppl. 2), 53-62.
56. Nieto, M., Monuki, E.S., Tang, H., Imitola, J., Haubst, N., Khoury, S.J., Cunningham, J., Gotz, M. and Walsh, C.A. (2004) Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex. J. Comp. Neurol., 479, 168-180.
57. Ferland, R.J., Cherry, T.J., Preware, P.O., Morrisey, E.E. and Walsh, C.A. (2003) Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J. Comp. Neurol., 460, 266-279.
58. Griffiths, P.D., Bolton, P. and Verity, C. (1998) White matter abnormalities in tuberous sclerosis complex. Acta Radiol., 39 482-486.
59. Makki, M.I., Chugani, D.C., Janisse, J. and Chugani, H.T. (2007) Characteristics of abnormal diffusivity in normal-appearing white matter investigated with diffusion tensor MR imaging in tuberous sclerosis complex. Am. J. Neuroradiol., 28, 1662-1667.
60. Del Rio, J.A., Heimrich, B., Borrell, V., Forster, E., Drakew, A., Alcantara, S., Nakajima, K., Miyata, T., Ogawa, M., Mikoshiba, K. et al. (1997) A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature, 385, 70-74.
61. Hirotsune, S., Fleck, M.W., Gambello, M.J., Bix, G.J., Chen, A., Clark, G.D., Ledbetter, D.H., McBain, C.J. and Wynshaw-Boris, A. (1998) Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat. Genet., 19, 333-339.
62. Corbo, J.C., Deuel, T.A., Long, J.M., LaPorte, P., Tsai, E., Wynshaw-Boris, A. and Walsh, C.A. (2002) Doublecortin is required in mice for lamination of the hippocampus but not the neocortex. J. Neurosci., 22, 7548-7557.
63. Gao, X. and Pan, D. (2001) TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev., 15, 1383-1392.
64. Potter, C.J., Huang, H. and Xu, T. (2001) Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell, 105, 357-368.
65. Galluzzi, P., Cerase, A., Strambi, M., Buoni, S., Fois, A. and Venturi, C. (2002) Hemimegalencephaly in tuberous sclerosis complex. J. Child Neurol., 17, 677-680.
66. Cartwright, M.S., McCarthy, S.C. and Roach, E.S. (2005) Hemimegalencephaly and tuberous sclerosis complex. Neurology, 64, 1634.
67. Chenn, A. and Walsh, C.A. (2002) Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science, 297 365-369.
68. Tang, B.L. (2006) Molecular genetic determinants of human brain size. Biochem. Biophys. Res. Commun., 345, 911-916.
69. Kuida, K., Haydar, T.F., Kuan, C.Y., Gu, Y., Taya, C., Karasuyama, H., Su, M.S., Rakic, P. and Flavell, R.A. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell, 94, 325-337.
70. Sessa, A., Mao, C., Hadjantonakis, A., Klein, W. and Broccoli, V. (2008) Tbr2 directs conversion of radial glia into basal precursors and guides neuronal amplification by indirect neurogenesis in the developing cortex. Neuron, 60, 56-69.
71. Correa-Cerro, L.S. and Mandell, J.W. (2007) Molecular mechanisms of astrogliosis: New approaches with mouse genetics. J. Neuropathol. Exp. Neurol., 66, 169-176.
72. Pekny, M. and Nilsson, M. (2005) Astrocyte activation and reactive gliosis. Glia, 50, 427-434.
73. Simons, M. and Trotter, J. (2007) Wrapping it up: The cell biology of myelination. Curr. Opin. Neurobiol., 17, 533-540.
74. Sher, F., Balasubramanian, V., Boddeke, E. and Copray, S. (2008) Oligodendrocyte differentiation and implantation: New insights for remyelinating cell therapy. Curr. Opin. Neurol., 21, 607-614.
75. Lee, M.J. and Stephenson, D.A. (2007) Recent developments in neurofibromatosis type 1. Curr. Opin. Neurol., 20, 135-141.
76. Butler, M.G., Dasouki, M.J., Zhou, X.P., Talebizadeh, Z., Brown, M., Takahashi, T.N., Miles, J.H., Wang, C.H., Stratton, R., Pilarski, R. et al. (2005) Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet., 42, 318-321.